Anti-BRINP3 antibodies are used in the immunodetection of the protein BMP/retinoic acid inducible neural specific 3. In humans, the canonical protein has a reported length of 766 amino acid residues and a mass of 88.4 kDa. Its subcellular localization is in the mitochondria and is secreted. Up to 2 different isoforms have been reported for this protein. It is reported to be highly expressed in oral keratinocytes compared to the weak expression in tongue squamous cell carcinoma (SCC). A member of the BRINP protein family, BRINP3 is reported to inhibit neuronal cell proliferation by negative regulation of the cell cycle transition. Post-translational modifications have been described, including glycosylation. Synonyms for this target antigen include DBCCR1-like protein 1, bone morphogenetic protein/retinoic acid inducible neural-specific 3, family with sequence similarity 5, member C, and BMP/retinoic acid-inducible neural-specific protein 3. BRINP3 gene orthologs have been reported in the mouse, rat, bovine, frog, chimpanzee and chicken species. Western Blot is a widely used application for the BRINP3 antibodies listed below. In addition, ELISA is also a common application.